NCT02162693View on ClinicalTrials.gov

Clinical Trial of Autologous Adipose Tissue-Derived Mesenchymal Progenitor Cells (MPCs) Therapy for Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

November 30, 2016

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

Mesenchymal progenitor cells

Administrated for intra-articular injection

BIOLOGICAL

Sodium Hyaluronate

Trial Locations (2)

200127

Shanghai Renji Hospital, Shanghai

Unknown

General Hospital of Chinese Armed Police Force, Beijing

All Listed Sponsors
collaborator

RenJi Hospital

OTHER

collaborator

General Hospital of Chinese Armed Police Force

UNKNOWN

lead

Shanghai AbelZeta Ltd.

INDUSTRY

NCT02162693 - Clinical Trial of Autologous Adipose Tissue-Derived Mesenchymal Progenitor Cells (MPCs) Therapy for Knee Osteoarthritis | Biotech Hunter | Biotech Hunter